Lifeward (NASDAQ:LFWD) Issues Earnings Results

Lifeward (NASDAQ:LFWD) released its quarterly earnings data on Friday. The company reported ($1.46) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.39) by ($0.07), FiscalAI reports. Lifeward had a negative net margin of 123.66% and a negative return on equity of 243.14%. The business had revenue of $6.62 million during the quarter, compared to the consensus estimate of $6.53 million.

Lifeward Trading Down 5.6%

NASDAQ:LFWD opened at $7.45 on Friday. Lifeward has a one year low of $4.14 and a one year high of $10.56. The business has a fifty day moving average price of $7.43 and a 200-day moving average price of $6.99. The firm has a market capitalization of $21.08 million, a price-to-earnings ratio of -0.44 and a beta of 0.38. The company has a debt-to-equity ratio of 1.16, a current ratio of 2.40 and a quick ratio of 1.82.

Wall Street Analysts Forecast Growth

LFWD has been the subject of several recent research reports. Zacks Research upgraded Lifeward from a “strong sell” rating to a “hold” rating in a research report on Monday, July 27th. Weiss Ratings raised Lifeward from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, August 3rd. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $10.00.

Hedge Funds Weigh In On Lifeward

Hedge funds have recently modified their holdings of the company. Citadel Advisors LLC increased its stake in Lifeward by 1,271.8% in the 3rd quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock worth $152,000 after buying an additional 198,406 shares in the last quarter. Jane Street Group LLC lifted its holdings in Lifeward by 77.3% in the 4th quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after purchasing an additional 29,927 shares in the last quarter. Virtu Financial LLC boosted its stake in Lifeward by 158.0% in the 4th quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock worth $35,000 after purchasing an additional 37,037 shares during the period. Finally, HRT Financial LP boosted its stake in Lifeward by 149.7% in the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after purchasing an additional 29,423 shares during the period. 26.76% of the stock is currently owned by institutional investors.

About Lifeward

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.